Growth and Tolerance of Infants Fed Formula for 16 Weeks

Growth Monitoring Study of Infants Fed Formula for 16 Weeks

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03487094

Enrollment

216

Registered

2018-04-03

Start date

2018-07-18

Completion date

2020-07-09

Last updated

2020-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child Development

Brief summary

Growth and Tolerance Trial of Iron-fortified infant formulas

Detailed description

16 WEEK GROWTH AND TOLERANCE

Interventions

OTHERInfant formula

Multi-centered, prospective, randomized clinical trial

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Masking description

Eligible infants are randomized to commercial control or experimental product.

Intervention model description

Multi-Investigator, Prospective, Randomized Clinical Trial

Eligibility

Sex/Gender

ALL

Age

1 Days to 14 Days

Healthy volunteers

Yes

Inclusion criteria

* Healthy term infants, 37-42 weeks gestational age

Exclusion criteria

* Any condition that would negatively impact assessment of growth and tolerance

Design outcomes

Primary

Measure	Time frame	Description
Growth	16 weeks	Weight Gain

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026